Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welnif-AT Tablets
Welnif-AT Tablets provide a balanced approach to hypertension management, combining the benefits of Nifedipine and Atenolol. This dual-action formulation supports better blood pressure control, reduces heart rate, and helps protect long-term cardiovascular health.
Uses of Welnif-AT Tablets
Treatment of high blood pressure (hypertension)
Management of stable angina pectoris
Helps control certain cardiac arrhythmias
Reduces the risk of cardiovascular complications in high-risk patients
Benefits of Welnif-AT Tablets
Dual mechanism of action, combining calcium channel blockade with beta-blockade
Proven efficacy in lowering blood pressure and heart rate
Convenient once-daily dosing for consistent blood pressure control
Well-tolerated therapy, offering a balanced approach to cardiovascular care
Recommended by healthcare providers for patients needing combination treatment
Mechanism of Action of Welnif-AT Tablets
Nifedipine relaxes blood vessels, improving blood flow and reducing resistance.
Atenolol slows the heart rate, reducing myocardial oxygen demand and lowering blood pressure.
Together, they provide a comprehensive and effective cardiovascular solution.
For best results, take Welnif-AT Tablets as directed by your healthcare provider. Maintain a healthy lifestyle, monitor your blood pressure regularly, and attend follow-up visits as recommended. Store in a cool, dry place and keep out of reach of children.